JCS 2017/JHFS 2017 Guideline on Diagnosis and Treatment of Acute and Chronic Heart Failure ― Digest Version ―

AHI apnea hypopnea index ANP atrial (A-type) natriuretic peptide ARB angiotensin II receptor blocker ASV adaptive servo-ventilation BNP brain (B-type) natriuretic peptide CABG coronary artery bypass grafting CKD chronic kidney disease COPD chronic obstructive pulmonary disease CPAP continuous positive airway pressure CRT cardiac resynchronization therapy CS clinical scenario CSA central sleep apnea CSR Cheyne-Stokes respiration CT computed tomography DOAC direct oral anticoagulant ECMO extracorporeal membrane oxygenation ESA erythropoiesis stimulating agent ESC European Society of Cardiology FiO2 fraction of inspiratory oxygen HF heart failure HFmrEF heart failure with mid-range ejection fraction HFpEF heart failure with preserved ejection fraction HFrecEF heart failure with recovered ejection fraction HFrEF heart failure with reduced ejection fraction IABP intra-aortic balloon pump ICD implantable cardioverter defibrillator IL interleukin JCS Japanese Circulation Society LVAD left ventricular assist device LVEF left ventricular ejection fraction MBP mean arterial pressure MRA mineralocorticoid receptor antagonist MRI magnetic resonance imaging NPPV noninvasive positive pressure ventilation NSAID nonsteroidal anti-inflammatory drug NT-proBNP N-terminal pro-brain (B-type) natriuretic peptide NYHA New York Heart Association OSA obstructive sleep apnea PaO2 arterial partial pressure of oxygen PCI percutaneous coronary intervention PCPS percutaneous cardiopulmonary support PDE phosphodiesterase QOL quality of life 2017 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure (Chair: Yancy) 8 2018